Achieving and maintaining a healthy lifestyle is a huge challenge for individuals across many sectors of today's global population, as well as for the healthcare professionals whose aim is to reduce cardiovascular disease (CVD) morbidity and mortality. Keesman et al. 1 have presented an excellent overview of factors influencing cardiovascular risk through lifestyle behaviours. They describe an ecosystem designed to address the challenges to living healthy lifestyles, highlighting the importance of co-creation and ongoing interaction between its various components. Their proposals are in keeping with current European Society of Cardiology (ESC) guidelines, 2 which recognise the value of combining individually targeted interventions with population level approaches, for both primary and secondary CVD prevention, and the importance of multisector collaboration and support for healthy lifestyle behaviours across an individual's lifespan.
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Declining rates of CVD mortality over the past four decades in many high-income countries have been attributed almost equally to risk factor control and major pharmacological and technological advances. However, more recent observations suggest that there is deceleration in the rate of decline, associated with increasing prevalence of obesity, type 2 diabetes and sedentary lifestyles, with implications for future levels of CVD morbidity. 3 Despite long-standing evidence of the effectiveness of secondary prevention, 4 evidence from the recent EUROASPIRE IV study 5 shows how, even with high levels of medication use, there remains a need for better risk factor management. That study found that levels of smoking cessation, obesity and physical inactivity amongst people with a history of cardiac events were sub-optimal for effective prevention. Whilst evidence of the effectiveness of primary prevention approaches using counselling or education to modify more than one cardiovascular risk factor in adults from general populations is poor, a recent Swedish study 6 has reported encouraging findings of the effects of combined individual and population level approaches. That study, comparing outcomes for two neighbouring populations, showed that such programmes were associated with significant improvements in blood pressure, fasting glucose and smoking prevalence, but not in other risk factors.
The BENEFIT ecosystem described by Keesman et al. 1 highlights the intricacy of planning that is required in order to establish effective linkages between the many influences, which extend beyond clinical practice, on cardiovascular health and lifestyle behaviours. Their paper acknowledges how the design of this ecosystem needs to be adapted to the context of its implementation, involving stakeholders in ongoing development and maintenance. Their ambitious vision will, if delivered successfully, provide comprehensive support for individuals, using both public and private resources. They recognise the range of factors which encourage unhealthy behaviours, the need to integrate different services and the risks of proposed electronic linkages failing to meet expected standards of performance.
Rigorous evaluation of the BENEFIT ecosystem will be needed in order to provide conclusive evidence of the value of the significant investment in organisational change that is proposed. The nature of that evaluation may be informed by The Medical Research Council's guidance 7 on the development and evaluation of complex health service interventions and should include a clear process evaluation, with reports of the fidelity of delivery of the system's various components, including sufficient detail to allow translation and replication of the ecosystem in other countries, if shown to be effective. Using a scientific framework in the development and evaluation of such a complex intervention will help to identify its 'active ingredients' and clear description of the context of its implementation will help to explain why it may or may not make its desired impact. Transparency in reporting should encourage stakeholders to continue their engagement with the system and its translation into practice in other settings.
Marked inequities in healthcare service provision and variations in risk factor levels across Europe 5 indicate that there is a need to adapt innovations in systems of care to specific populations. The emphasis of change in how cardiovascular healthcare and disease prevention are delivered will vary between and within countries. Descriptions of clinical, social, environmental and administrative elements of the ecosystem's development and delivery are important, given the current inequities of access to and uptake of programmes of primary and secondary CVD prevention and treatments. Identification of relevant stakeholders in different settings is essential, to help ensure the appropriateness of system design locally and awareness of barriers, facilitators and beliefs of local communities regarding CVD prevention. Co-creation and a sense of ownership are essential elements of successful innovations.
As Keesman et al. 1 suggest, the use of digital technologies should lead to better cross-sector co-operation, providing optimal opportunities for multi-party interaction and collaborative working. Use of these technologies has extended horizons of healthcare provision and facilitated the delivery of services such as rehabilitation to people living remotely from centres of care. Improved dissemination of information, both between professionals in different services and between professionals and patients, is an obvious benefit but the legal and ethical constraints which may challenge successful implementation also require consideration. Integrating new technologies into healthcare systems is often difficult, requiring organisational change, new governance arrangements, revision of budgetary resource allocations, and acceptance by stakeholders, with willingness to adapt their processes of practice. A recent position paper published by the ESC 8 provides a comprehensive outline of the various domains of e-health, many of which are relevant to the development of the BENEFIT ecosystem, and the challenges and opportunities that their use may bring.
Whilst it is important to harness technology and to extend access to cost effective models of healthcare and service provision for all sectors of the population, the role of paper tools must not be forgotten. Both patients and healthcare professionals in primary care practice who have used a paper-based decision support tool, for health behaviour change relating to CVD prevention, have welcomed its ease of access as a source of guidance and reference, without using electronic technology. 9 There is a need to consider how increasing reliance on technological innovation may increase health inequalities, making information more accessible to younger, health literate members of the population and neglecting the needs of older individuals, with lesser levels of health literacy and technological skill, and more limited opportunities of access to electronic resources.
Comprehensive, integrated support captured within a public-private ecosystem, such as described by Keesman et al., 1 which recognises the need to target interventions to individuals in order to make a sustained impact on healthy living augers well for success in decreasing the burden of CVD. Initiatives which support healthy behaviours may also require changes in public policy, development of personal skills and practical examples of support for healthy eating, physical activity and non-smoking by health services and professionals. 10 The BENEFIT ecosystem 1 considers the impact of social, physical and fiscal environments, recognising that various agencies, as well as healthcare professionals, need to be actively involved in making 'the healthier choice the easier choice' for individuals. 10 It takes account of many factors, including the risks of resumption of unhealthy habits after a successful shortterm individually focused intervention.
The recommendations of the first combined Task Force of the European Societies regarding prevention of coronary heart disease, published in 1994, focused on clinical practice and represented the first important step in specialist collaboration towards this goal. Their recognition of the powerful political, economic and social determinants of atherosclerotic disease and consequent need for a population strategy has gained increasing emphasis over time. 2, 10 It is to be hoped that successful delivery of the proposed ecosystem 1 may make a significant impact on acceleration of the integration of preventive approaches based on lifestyle behaviours into clinical practice for all health professionals working in hospital and in primary healthcare. Provision of convincing evidence of its effectiveness would be welcomed in supporting implementation of the most recent ESC guidelines for CVD prevention 2 for the benefit of both individuals and populations.
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